Search

everythinglearnresearchcommunity

for

Search:↓

The treatment showed high response rates and was well-tolerated, potentially extending patient survival.

A multi-drug treatment can effectively clear extensive calcinosis in juvenile dermatomyositis.

A woman with X-linked chronic granulomatous disease developed lupus-like skin lesions, improved with treatment, suggesting a unique skin condition in carriers.

The new aptamer TAGX-0003 shows promise as an effective treatment for hair loss disorder alopecia areata.

SOCS3 treatment can prevent hair loss by stopping harmful immune responses.

Tofacitinib nanoparticles can safely and effectively treat alopecia areata by targeting hair follicles.

Genetic screening for NUDT15 polymorphisms is crucial for patients taking azathioprine, especially in Asians.

The rash resolved after stopping ponatinib.

Hydroxychloroquine is less effective than betamethasone oral mini pulse therapy for treating alopecia areata.

Machine learning can predict how well patients with alopecia areata will respond to certain treatments.

Tofacitinib helped regrow hair in a woman with alopecia areata.

Using tacalcitol ointment with photodynamic therapy may effectively treat follicular mucinosis with scalp hair loss.

The gel is safe and effective for treating oral mucositis from chemotherapy and radiation.

Tofacitinib effectively treated a woman's severe symptoms from a rare autoimmune condition.

Biosimilars lower costs but don't significantly improve access.

A 15-year-old boy's severe scalp condition improved significantly with adalimumab and baricitinib treatment.

Upadacitinib may effectively treat both alopecia universalis and Crohn's disease.

Tofacitinib may be an effective and safe treatment for hair loss in teenagers with alopecia areata.

Follicular mucinosis in a 15-year-old is usually harmless but needs monitoring for possible lymphoma.

Apremilast did not work for treating severe alopecia areata.

Dexamethasone-primed stem cell media shows promise in treating lupus by reducing symptoms and inflammation.

Combining excimer lamp and tofacitinib gel may help treat hair loss in children.

The study created a mouse model that survives longer and shows fewer symptoms of pemphigus vulgaris.

A man with vitiligo and alopecia saw quick skin and hair improvement with ruxolitinib, but skin color gains were lost after stopping treatment.

The boy's severe skin disorder is caused by two new mutations in his TGM1 gene.

A patient with alopecia had hair regrowth with tofacitinib but developed a skin reaction, choosing to continue the treatment despite the side effect.

The drug BAY 1158061 is safe, well-tolerated, and shows potential for treating diseases related to prolactin.

Cromolyn sodium's effectiveness for treating asthma in children under 2 is unclear, possibly more beneficial for older children, and further research is needed.